Danaher Corp. stock faces pressure amid life sciences slowdown and biotech funding crunch

Danaher Corp. (ISIN: US2358511028) stock trades on NYSE in USD, grappling with weaker demand in biotechnology tools and diagnostics as US biotech funding dries up. Investors watch for Q1 guidance as operating margins compress. Why US portfolios should monitor this industrials leader now.